Clinical Trial Update: Life 4°C Versus Optisol in Corneal Storage Media [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Life 4°C vs Optisol in corneal storage media for corneal transplant complications has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Graft Failure-related Conditions
• Corneal Transplant Complications

Drugs mentioned

• Life 4°C
• Optisol

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Complications of Corneal Transplant | Phase 3 | Status: COMPLETED | Results posted: 2022-04-18